M

Myomo Inc
AMEX:MYO

Watchlist Manager
Myomo Inc
AMEX:MYO
Watchlist
Price: 1.03 USD -4.63%
Market Cap: 39.6m USD

Myomo Inc
Long-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Myomo Inc
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
M
Myomo Inc
AMEX:MYO
Long-Term Debt
$1.3m
CAGR 3-Years
N/A
CAGR 5-Years
76%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Long-Term Debt
$17.6B
CAGR 3-Years
8%
CAGR 5-Years
0%
CAGR 10-Years
4%
Boston Scientific Corp
NYSE:BSX
Long-Term Debt
$11.1B
CAGR 3-Years
9%
CAGR 5-Years
4%
CAGR 10-Years
7%
Stryker Corp
NYSE:SYK
Long-Term Debt
$14.8B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
19%
Abbott Laboratories
NYSE:ABT
Long-Term Debt
$11.6B
CAGR 3-Years
-9%
CAGR 5-Years
-9%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Myomo Inc
Glance View

Market Cap
38.9m USD
Industry
Health Care

Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The company is headquartered in Boston, Massachusetts and currently employs 100 full-time employees. The company went IPO on 2017-06-12. The firm offers functional improvement for those with neuromuscular disorders and upper limb paralysis. The firm develops and markets the MyoPro product line. The MyoPro is a myoelectric-controlled upper limb brace (orthosis). The orthosis is a rigid brace used for the purpose of supporting a patient’s weak or paralyzed arm to enable and help improve functional activities of daily living (ADLs), in the home and community. The MyoPro can enable individuals to self-initiate and control movements of a partially paralyzed or weakened limb using their own muscle signals. The Company’s products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury and other neurological disorders. The company primarily provides devices directly to patients and bills their insurance companies.

MYO Intrinsic Value
1.61 USD
Undervaluation 36%
Intrinsic Value
Price
M

See Also

What is Myomo Inc's Long-Term Debt?
Long-Term Debt
1.3m USD

Based on the financial report for Jun 30, 2025, Myomo Inc's Long-Term Debt amounts to 1.3m USD.

What is Myomo Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
76%

Back to Top